  | Chauffier, J., Jachiet, V., Battistella, M., Romero, P., Fenaux, P., Zakine, E., Zhao, L. P., Mahévas, T., Bouaziz, J.-D., Hadjadj, J., Amoura, Z., Mathian, A., Breillat, P., Hirsch, P., Bourguiba, R., De Voeght, A., Grobost, V., Begon, E., Jandus, P., ... EMSED Group and MINHEMON Group. (2025). Lupuslike Manifestations in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia. JAMA Dermatology. doi:10.1001/jamadermatol.2025.4586  Peer Reviewed verified by ORBi |
 | Stammler, R., Chen, P., Debeaupuis, O., Zhao, L. P., Ruyer‐Thompson, M., Zakine, E., Rossignol, J., Goldwirt, L., Comont, T., Heiblig, M., Adès, L., Sebert, M., Allain, J. S., Campagne, J., Couturier, M. A., Cumin, M., Dalmas, M. C., Denis, G., Devloo, C., ... Mékinian, A. (November 2025). Inflammatory disorders in IDH‐mutated myeloid neoplasms: Characteristics and response to IDH inhibitors. HemaSphere, 9 (11). doi:10.1002/hem3.70256 Peer Reviewed verified by ORBi |
 | Lopez Delhoulle, V., De Voeght, A., NECHIFOR - POTORAC, I., Sépulchre, E., Willems, E., Pétrossians, P., Fernandez Carazo, R., KOOPMANSCH, B., Docampo Martínez, E., Bours, V., Bulk, S.* , & Lambert, F.*. (16 October 2025). A Spectrum of Tumorigenesis in an IDH1-Mosaic Patient with Ollier Disease [Poster presentation]. 7th INTERNATIONAL CONFERENCE ACUTE MYELOID LEUKEMIA “MOLECULAR AND TRANSLATIONAL”: ADVANCES IN BIOLOGY AND TREATMENT, Estoril, Portugal. Peer reviewed* These authors have contributed equally to this work. |
 | Maertens, J., R. Herbrecht, S. Fodil, De Voeght, A., K. Delavigne, T. Liebregts, R. Rodriguez Veiga, J. De Greef, M. Uzunov, L. Vazquez10, O. Penack, A. Albasanz-Puig, M.C. Ngirabacu, V. Mehra, D. Teschner, L. Albert, C. Pfeifer, P. Brennan-Benson, K. Vanstraelen, & E. Azoulay. (July 2025). Real-world dataset demonstrates favorable safety profile of liposomal amphotericin B for the treatment of invasive aspergillosis in high-risk haemato-oncology patients [Poster presentation]. ESCMID Global 2025. Editorial reviewed |
 | Lukas Haaksma, Gwendolyn Van Gorkom, Tom Reuvekamp, Andrius Žučenka, De Voeght, A., Vladimir Lazarevic, Dries Deeren, Evy Billen, Kasper Croese, Jesse Tettero, Patrycja Gradowska, Bob Löwenberg, Gert Ossenkoppele, Jeroen J. W. M. Janssen, Jacqueline Cloos, David de Leeuw, & Catharina Van Elssen. (June 2025). (PS1481) SECOND INDUCTION CYCLE BEFORE ALLOHSCT DOES NOT IMPROVE SURVIVAL IN ADVERSE-RISK AML PATIENTS IN COMPLETE REMISSION AFTER FIRST INDUCTION. HemaSphere, 9 (S1). doi:10.1002/hem3.70152 Peer Reviewed verified by ORBi |
  | Daver, N. G., Vyas, P., Huls, G. A., Döhner, H., Maury, S., Novak, J., Papayannidis, C., Martinez Chamorro, C., Montesinos, P., Niroula, R., Fenaux, P., Esteve, J., Wu, S.-J., De Voeght, A., Mayer, J., Valk, P. J. M., Johnson, L., Dong, M., Liu, K., ... Guru Murthy, G. S. (2025). The ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapy. Blood. doi:10.1182/blood.2024027506 Peer Reviewed verified by ORBi |
 | Faville, C., E Silva, B., Vilanova Mana, L., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M., Willems, L., & Ehx, G. (18 March 2025). Optimization Of An MHC-I immunoprecipitation Protocol For Mass Spectrometry Analyses Of Persister-Specific Antigens In Acute Myeloid Leukemia [Poster presentation]. EACR Conference "Persister Cells: from Bacteria to Cancer". |
 | De Voeght, A.* , KOOPMANSCH, B.* , MENTEN, C., Fernandez Carazo, R., Keutgens, A., Tassin, F., Somja, J., Collins, P., SIMUL, M., DE PRIJCK, B., Foguenne, J.* , & LETE, C.*. (07 February 2025). Aggressive Hematological Neoplasms Involving Plasmacytoid Dendritic Cells: A Three-Case Serie [Poster presentation]. 40th General Annual Meeting of the Belgian Hematology Society 2025. Editorial reviewed* These authors have contributed equally to this work. |
 | Lemhamdi, O., De Voeght, A., Hayette, M.-P., DE PRIJCK, B., Willems, E., Baron, F., & Caers, J. (February 2025). Diagnostic and Therapeutic Approaches to Mucormycosis : A Monocentric Cohort Study [Poster presentation]. 40th General Annual Meeting. |
  | GILLARD, R., Jadoul, A., De Voeght, A., & PONGHIS, G. (2025). Cas clinique : masse médiastinale prévasculaire. Revue Médicale de Liège, 80, 12-17. Editorial Reviewed verified by ORBi |
 | Maertens, J., Van Obbergh Florence, De Voeght, A., De Beule Nathan, HAVELANGE Violaine, JANSSENS Michael, SELIM Sid, MEERS Stef, MAERTENS Vincent, VANDEWEERD Laura, XU Yilin, BURNE Rebecca, & Goldberg Aaron. (2025). Real-World Outcomes of Belgian Patients with Newly Diagnosed Acute Myeloid Leukaemia Treated with Venetoclax and Azacitidine: A Multicentre Chart Review Study [Paper presentation]. 40th General Annual Meeting of the Belgian Hematology Society 2025. Editorial reviewed |
 | Maertens, J., R Herbrecht, S Fodil, De Voeght, A., De lavigne, K., Liebregts T, Rodriguez-Veiga, R., De greef, J., Uzunov, M., Vasquez, L., Penack, O., Albasanz-Puig, A., Ngirabacu, M. C., Mehra, V., Teschner, D., Albert, L., Pfeifer, C., Brennan_Benson P, Vanstraelen, K., & Azoulay, E. (2025). P127 Real-world dataset demonstrates favorable safety profile of Liposomal amphotericin B primary treatment of invasive aspergillosis in haemato-oncology patients [Poster presentation]. 12th Trends in Medical Mycology. Peer reviewed |
 | De Voeght, A., Aaron D. Goldberg, Florence Van Obbergh, Nathan De Beule, Laura Vandeweerd, Barbara Gillon, Yanqing Xu, Rebecca Burne, & Johan Maertens. (2025). OUTCOMES OF PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX AND AZACITIDINE IN REAL-WORLD BELGIAN CLINICAL PRACTICE [Poster presentation]. EHA2025. Peer reviewed |
 | SAKALIHASAN, S., LIFRANGE, F., CZAJKOWSKI, M., GONCETTE, V., Duysinx, B., Lovinfosse, P., Can, D., Schils, R., Hayette, M.-P., & De Voeght, A. (2024). Severe Dual Fungal Infection After Bispecific Antibody Therapy: A Case of Invasive Aspergillosis and Mucormycosis in Immunocompromised Patient. IDCases, 02140. doi:10.1016/j.idcr.2024.e02140 Peer Reviewed verified by ORBi |
 | De Voeght, A. (06 November 2024). Fungal Infections in Hematology [Paper presentation]. Joint Meeting SFMM – BSHAM. |
| Faville, C., E Silva, B., Cobraiville, G., Ehx, G., Fillet, M., Baron, F., De Voeght, A., Vilanova Mana, L., Willems, L., Baiwir, D., & Mazzucchelli, G. (October 2024). Optimization of an MHC-I immunoprecipitation protocol for mass spectrometry analyses of persister-specific antigens in acute myeloid leukemia [Paper presentation]. yBIS: 1st annual meeting. |
| Malaise, O., Von Frenckell, C., Mina, M., Rinkin, C., DAMSIN, T., GESTER, F., El Moussaoui, M., PAQUOT, C., Lambert, F., De Voeght, A., Ribbens, C., & VERTENOEIL, G. (18 September 2024). VEXAS syndrome: at the intersection between rheumatology and hematology. But have we thought about inviting the dermatologist? [Poster presentation]. Belgian Congress of Rheumatology 2024. Peer reviewed |
| Faville, C., E Silva, B., Vilanova Mana, L., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M., Mazzucchelli, G., Ehx, G., Baiwir, D., & Willems, L. (September 2024). Optimization Of An MHC-I immunoprecipitation Protocol For Mass Spectrometry Analyses Of Persister-Specific Antigens In Acute Myeloid Leukemia [Poster presentation]. GIGA Day. |
 | Pirnay, J.-P., Djebara, S., Steurs, G., Griselain, J., Cochez, C., De Soir, S., Glonti, T., Spiessens, A., Vanden Berghe, E., Green, S., Wagemans, J., Lood, C., Schrevens, E., Chanishvili, N., Kutateladze, M., de Jode, M., Ceyssens, P.-J., Draye, J.-P., Verbeken, G., ... Guiot, J. (Other coll.). (2024). Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nature Microbiology. doi:10.1038/s41564-024-01705-x Peer Reviewed verified by ORBi |
 | Dierickx, D., Connerotte, T., Dallemagne, J., De Becker, A., Moors, I., Snauwaert, S., Sonet, A., Theunissen, K., Breems, D., De Voeght, A., JASPERS, A., Lambert, C., Heyrman, B., Hautekiet, J., Lyna, S., Maertens, C., & Delrieu, V. (2024). Real-World Insights on the Management of Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP) With Caplacizumab. Blood Vessels, Thrombosis and Hemostasis, 100008. doi:10.1016/j.bvth.2024.100008 Peer reviewed |
 | MAQUET, C., DE PRIJCK, B., JASPERS, A., Tassin, F., Keutgens, A., Beguin, Y., & De Voeght, A. (May 2024). Front-line venetoclax monotherapy for blastic plasmacytoid dendritric cell neoplasm. Belgian Journal of Hematology, 15 (3), 125-129. Peer Reviewed verified by ORBi |
 | Faville, C.* , E Silva, B.* , Jassin, M., DUBOIS, S., Daulne, C., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M.* , & Ehx, G.*. (06 February 2024). Discovery And Targeting of Persister-specific Antigens in Acute Myeloid Leukemia [Poster presentation]. Télévie Seminar. * These authors have contributed equally to this work. |
 | Faville, C.* , E Silva, B.* , Jassin, M., DUBOIS, S., Daulne, C., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M.* , & Ehx, G.*. (06 February 2024). Discovery And Targeting of Persister-specific Antigens in Acute Myeloid Leukemia [Paper presentation]. Télévie Seminar. * These authors have contributed equally to this work. |
| De Voeght, A. (02 February 2024). AML: new therapies - current and future [Paper presentation]. 39th General Annual Meeting of the Belgian Hematology Society 2024. |
 | Pirotte, M., De Voeght, A., VERTENOEIL, G., Vasbien Myriam, Paridaens, H., Somja, J., Collins, P., & Lambert, F. (December 2023). VACUOLES, E1 ENZYME, X-LINKED, AUTOINFLAMMATORY, SOMATIC SYNDROME (VEXAS SYNDROME) WITH MULTIPLE THROMBOEMBOLISM EVENTS: A BELGIAN CASE REPORT. Belgian Journal of Hematology, 14 (8), 336–42. Peer Reviewed verified by ORBi |
 | De Voeght, A. (October 2023). MAGROLIMAB: A NEW WEAPON AGAINST CANCER CELLS. Belgian Journal of Hematology, 14 (6), 250–4. Peer Reviewed verified by ORBi |
 | E Silva, B., Faville, C., Jassin, M., DUBOIS, S., De Voeght, A., Baron, F., & Ehx, G. (09 September 2023). Characterizing the immune recognition of chemo-persister blasts in acute myeloid leukemia [Poster presentation]. GIGA Day 2023. |
 | De Voeght, A., WILLEMS, E., Servais, S., Seidel, L., Pirotte, M., Massion, P., Layios, N., Pereira, M., Misset, B., CANIVET, J.-L., Beguin, Y., & Baron, F. (31 August 2022). Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) Scores. Cancers, 14 (17), 4266. doi:10.3390/cancers14174266 Peer Reviewed verified by ORBi |
 | DE VOEGHT, A. (15 October 2021). Thrombotic Microvascular Injury is not Mediated by Thrombotic Micro Angiopathy Despite Systemic Complement Activation in COVID-19 Patients. Journal of Blood Disorders and Transfusion, 12. Peer Reviewed verified by ORBi |
 | DE VOEGHT, A., JASPERS, A., BEGUIN, Y., Baron, F., & DE PRIJCK, B. (2021). Principes généraux de la prise en charges des leucémies aiguës de l’adulte en 2021 en Belgique. Revue Médicale de Liège, 76, 470-475. Peer reviewed |
 | DE VOEGHT, A., CALMES, D., BECK, F., SYLVESTRE, J.-B., DELVENNE, P., PETERS, P., VERTENOEIL, G., BARON, F., LAYIOS, N., & CANIVET, J.-L. (2020). Thrombotic microvascular injury is not mediated by thrombotic microangiopathy despite systemic complement activation in Covid-19 patients. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/256301. |
 | DE VOEGHT, A., Godon, E., Chachati, A., CAVALIER, E., & Buysschaert, B. (2019). HYPERCALCÉMIE SUR INTOXICATION À LA VITAMINE D : VIGNETTE CLINIQUE ET REVUE DE LA LITTÉRATURE. Louvain Medical. Peer reviewed |
 | Delmotte, V., Foidart, P., DE VOEGHT, A., LEJEUNE, M., & Delwaide, J. (2019). Diagnostic différentiel de l’anémie dans la cirrhose éthylique. Revue Médicale de Liège, 74 (10), 527-534. Peer reviewed |
 | Schweich, M., DE VOEGHT, A., Sacre, F., BERNARD, V., & Michels, V. (2018). Scorbut, maladie historique ? Revue Médicale de Liège, 73:11, 541-543. Peer reviewed |
 | DE VOEGHT, A., Martens, H., RENARD, J. D. C., VAIRA, D., Debruche, M., Simonet, J., Geenen, V., MOUTSCHEN, M., & DARCIS, G. (2017). Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium. PLoS ONE. doi:10.1371/journal.pone.0185761 Peer Reviewed verified by ORBi |
 | DE VOEGHT, A., Maes, N., & Moutschen, M. (27 March 2016). sCD14 is not a bona-fide biomarker of microbial translocation in HIV-1 infected Africans living in Belgium. AIDS, 30 (6), 921-4. doi:10.1097/QAD.0000000000000996 Peer Reviewed verified by ORBi |
 | DE VOEGHT, A., SAUVAGE, A.-S., GENSBURGER, M., GIOT, J.-B., & Moutschen, M. (2016). Tuberculose miliaire chez une patiente sous adalimumab. Revue Médicale de Liège, 71 (7-8), 328-331. Peer reviewed |
 | Pirotte, B., Rassenfosse, M., Collin, R., De Voeght, A., MOUTSCHEN, M., & CAVALIER, E. (2013). Rôle de la vitamine D dans l'infection par le VIH: revue des connaissances actuelles. Revue Médicale de Liège, 68 (1), 25-31. Peer reviewed |
